MedTrace Logo

Scooping Mobilization With and Without Scapulothoracic Mobilization in Patients of Lateral Epicondylalgia

NCT06869733 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2025-03-11

No results posted yet for this study

Summary

Lateral epicondylalgia is well known musculoskeletal disorder now a day. Lateral epicondylalgia is a disorder in which pain and tenderness at lateral part of elbow. This study is targeting the scapulothoracic mobilization and scooping mobilization at lateral epicondylalgia. This study is single-blinded Randomized Clinical Trial will be conducted in Fatima memorial Hospital and Bajwa hospital Lahore. Non-probability convenience sampling will be used with 38 Participants involved in this study is with age of 18 to 45 with presence of pain and tenderness around lateral epicondyle, positive Cozens test and maudsley test, scapular dyskinesia, pain on resisted elbow extension, wrist extension and gripping activities. In this study, one group is treated with scooping mobilization with scapulothoracic mobilization. Second group is treated with scooping mobilization alone. The participants will be randomized into two Groups by computer generated randomization software. Outcomes measures which are used in this study is Numeric pain rating scale for pain, goniometer for range of motion and patient related tennis elbow evaluation for activities of daily livings for patients of lateral epicondylalgia.

Conditions

  • Lateral Epicondylitis

Interventions

OTHER

Scooping Mobilization

Group A treated with only scooping mobilization with frequency of 2 to 3 times in a week for consecutive 4 weeks.

OTHER

Scooping Mobilization with Scapulothoracic mobilization

Group B treated with scooping mobilization with scapulothoracic mobilization, which was given 2 to 3 times in a week for consecutive 4 weeks.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Humera Mubashar, MSOMPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-02
Primary Completion
2023-12-23
Completion
2024-07-02

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06869733 on ClinicalTrials.gov